ReviewClinical and experimental nephrology2021
iPSC technology-based regenerative medicine for kidney diseases.
Kenji OsafunePubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
16 papers cite it
this papercites it
ReviewClinical and experimental nephrology2021
Kenji OsafunePubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.